Want to see TSE:CRRX full AI Analyst Report?
CareRx (CRRX) Ratios
CareRx Ratios
TSE:CRRX's free cash flow for Q2 2026 was $1.92M. For the 2026 fiscal year, TSE:CRRX's free cash flow was decreased by $-1.11M and operating cash flow was $3.04M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.06 | 0.99 | 1.05 | 1.40 | 1.80 |
| Quick Ratio | 0.78 | 0.71 | 0.73 | 1.08 | 1.46 |
| Cash Ratio | 0.23 | 0.14 | 0.11 | 0.44 | 0.67 |
| Solvency Ratio | 0.31 | 0.11 | 0.10 | -0.07 | -0.04 |
| Operating Cash Flow Ratio | 0.44 | 0.60 | 0.44 | 0.35 | 0.14 |
| Short-Term Operating Cash Flow Coverage | 5.40 | 7.13 | 2.76 | 3.01 | 9.92 |
| Net Current Asset Value | $ -76.50M | $ -76.97M | $ -84.95M | $ -110.90M | $ -105.28M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.31 | 0.37 | 0.42 | 0.51 | 0.44 |
| Debt-to-Equity Ratio | 0.71 | 0.98 | 1.20 | 2.10 | 1.53 |
| Debt-to-Capital Ratio | 0.42 | 0.50 | 0.55 | 0.68 | 0.60 |
| Long-Term Debt-to-Capital Ratio | 0.25 | 0.32 | 0.41 | 0.61 | 0.58 |
| Financial Leverage Ratio | 2.31 | 2.65 | 2.84 | 4.10 | 3.44 |
| Debt Service Coverage Ratio | 4.30 | 1.64 | 1.19 | 0.04 | 0.55 |
| Interest Coverage Ratio | 1.74 | 0.49 | 0.33 | -1.44 | -0.19 |
| Debt to Market Cap | 0.17 | 0.36 | 0.73 | 0.88 | 0.57 |
| Interest Debt Per Share | 1.35 | 1.52 | 1.96 | 3.16 | 4.10 |
| Net Debt to EBITDA | 2.23 | 3.08 | 3.68 | -175.17 | 9.98 |
| Profitability Margins | |||||
| Gross Profit Margin | 25.02% | 29.47% | 22.85% | 28.80% | 28.66% |
| EBIT Margin | 2.75% | 1.29% | 1.26% | -5.42% | -2.43% |
| EBITDA Margin | 7.71% | 6.52% | 6.65% | -0.16% | 3.43% |
| Operating Profit Margin | 3.21% | 1.23% | 1.26% | -5.75% | -1.26% |
| Pretax Profit Margin | 0.91% | -1.22% | -2.59% | -9.40% | -9.04% |
| Net Profit Margin | 7.06% | -1.23% | -1.46% | -9.00% | -8.65% |
| Continuous Operations Profit Margin | 7.06% | -1.23% | -1.46% | -9.00% | -8.65% |
| Net Income Per EBT | 779.21% | 100.72% | 56.33% | 95.70% | 95.77% |
| EBT Per EBIT | 28.22% | -98.76% | -205.46% | 163.58% | 717.72% |
| Return on Assets (ROA) | 10.33% | -2.01% | -2.33% | -12.99% | -8.04% |
| Return on Equity (ROE) | 23.86% | -5.34% | -6.63% | -53.30% | -27.62% |
| Return on Capital Employed (ROCE) | 6.25% | 2.82% | 2.76% | -10.94% | -1.44% |
| Return on Invested Capital (ROIC) | 6.01% | 2.68% | 1.44% | -9.97% | -1.37% |
| Return on Tangible Assets | 16.95% | -3.78% | -4.60% | -24.27% | -16.70% |
| Earnings Yield | 10.90% | -3.63% | -5.85% | -28.19% | -11.46% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.25 | 11.06 | 10.27 | 10.24 | 6.89 |
| Payables Turnover | 8.19 | 8.13 | 9.83 | 8.92 | 5.64 |
| Inventory Turnover | 15.82 | 14.64 | 14.55 | 13.39 | 10.41 |
| Fixed Asset Turnover | 6.82 | 6.45 | 7.11 | 7.29 | 6.88 |
| Asset Turnover | 1.46 | 1.64 | 1.60 | 1.44 | 0.93 |
| Working Capital Turnover Ratio | 210.66 | 293.72 | 26.24 | 11.30 | 11.91 |
| Cash Conversion Cycle | 10.94 | 13.01 | 23.47 | 21.96 | 23.32 |
| Days of Sales Outstanding | 32.44 | 32.99 | 35.53 | 35.63 | 52.96 |
| Days of Inventory Outstanding | 23.07 | 24.94 | 25.08 | 27.27 | 35.05 |
| Days of Payables Outstanding | 44.56 | 44.92 | 37.15 | 40.93 | 64.69 |
| Operating Cycle | 55.50 | 57.93 | 60.61 | 62.89 | 88.02 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.44 | 0.63 | 0.48 | 0.47 | 0.21 |
| Free Cash Flow Per Share | 0.35 | 0.50 | 0.33 | 0.18 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | 4.02 | 4.68 | 3.15 | 1.64 | 1.02 |
| Capital Expenditure Coverage Ratio | 4.93 | 4.68 | 3.15 | 1.64 | 1.02 |
| Operating Cash Flow Coverage Ratio | 0.35 | 0.46 | 0.28 | 0.17 | 0.06 |
| Operating Cash Flow to Sales Ratio | 0.07 | 0.10 | 0.07 | 0.06 | 0.03 |
| Free Cash Flow Yield | 9.16% | 24.07% | 20.23% | 7.16% | 0.08% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 9.10 | -27.58 | -17.08 | -3.55 | -8.73 |
| Price-to-Sales (P/S) Ratio | 0.65 | 0.34 | 0.25 | 0.32 | 0.76 |
| Price-to-Book (P/B) Ratio | 2.19 | 1.47 | 1.13 | 1.89 | 2.41 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 10.92 | 4.15 | 4.94 | 13.97 | 1296.35 |
| Price-to-Operating Cash Flow Ratio | 8.70 | 3.27 | 3.37 | 5.46 | 27.29 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 1.33 | 0.20 | -0.33 | 0.31 |
| Enterprise Value Multiple | 10.63 | 8.27 | 7.43 | -374.92 | 31.99 |
| Enterprise Value | 303.17M | 197.67M | 183.17M | 228.70M | 288.29M |
| EV to EBITDA | 10.63 | 8.27 | 7.43 | -374.92 | 31.99 |
| EV to Sales | 0.82 | 0.54 | 0.49 | 0.60 | 1.10 |
| EV to Free Cash Flow | 13.81 | 6.62 | 9.81 | 26.23 | 1884.26 |
| EV to Operating Cash Flow | 11.01 | 5.20 | 6.69 | 10.24 | 39.66 |
| Tangible Book Value Per Share | 0.17 | -0.33 | -0.57 | -1.23 | -1.85 |
| Shareholders’ Equity Per Share | 1.75 | 1.40 | 1.42 | 1.35 | 2.36 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -6.79 | -0.01 | 0.44 | 0.04 | 0.04 |
| Revenue Per Share | 5.90 | 6.09 | 6.46 | 8.02 | 7.53 |
| Net Income Per Share | 0.42 | -0.07 | -0.09 | -0.72 | -0.65 |
| Tax Burden | 7.79 | 1.01 | 0.56 | 0.96 | 0.96 |
| Interest Burden | 0.33 | -0.95 | -2.05 | 1.74 | 3.72 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.09 | 0.09 | 0.08 | 0.27 | 0.27 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 |
| Income Quality | 1.05 | -8.44 | -5.06 | -0.65 | -0.32 |
Currency in CAD
